COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,155 Articles (22,703 medRxiv, 8,452 bioRxiv)

Most recent first Previous |  Page 2123: Articles 21221-21230  | Next

Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil
Sales, M. J. T., Kerr, L. S., Brizolara, R. V., Barreto, I. C. d. H. C., Almeida, R. L. F., Goes, P., Andrade, L. O. M. d., Torres, L., Pinto, F. K. A., Pinheiro-Junior, F. M. L., Leite, R. V., Abreu, A. C. A. F. C. d., Theophilo, R. L., Magalhaes, F. R., Silva, S. L. d., Kendall, C.
10.1101/2020.10.22.20216010 — Posted: 2020-10-27
Challenges for non-technical implementation of digital proximity tracing: early experiences from Switzerland
von Wyl, V.
10.1101/2020.10.22.20218057 — Posted: 2020-10-27
The importance of the human factor during the evolution of SARS-CoV-2 pandemic: the successful case of the Italian strategy
Scarpazza, C., Musumeci, G., Camperio Ciani, A. S.
10.1101/2020.10.22.20215277 — Posted: 2020-10-27 Discussion: Onsite
Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: The care must go on
Casper, M., Reichert, M. C., Rissland, J., Casper, M., Lammert, F., Krawczyk, M.
10.1101/2020.10.22.20217885 — Posted: 2020-10-27
Frailty and comorbidity in predicting community COVID-19 mortality in the UK Biobank: the effect of sampling
Mak, J. K. L., Kuja-Halkola, R., Wang, Y., Hagg, S., Jylhava, J.
10.1101/2020.10.22.20217489 — Posted: 2020-10-27
Positive outcomes of COVID-19 research-related gender policy changes
Witteman, H. O., Haverfield, J., Tannenbaum, C.
10.1101/2020.10.26.355206 — Posted: 2020-10-26
Origin of imported SARS-CoV-2 strains in The Gambia identified from whole genome sequences
Kanteh, A., Manneh, J., Jabang, S., Mariama A., K., Bakary, S., Mary A., O., Bojang, A., Jallow, H., Nwakanma, D., Secka, O., Rocca, A., Amambua-Ngwa, A., Antonio, M., Baldeh, I., Forrest, K., Samateh, A. L., DAlessandro, U., Sesay, A. K.
10.1101/2020.10.26.354969 — Posted: 2020-10-26
Comparison of the in vitro-efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
Steinhauer, K., Meister, T. L., Todt, D., Krawczyk, A., Passvogel, L., Becker, B., Paulmann, D., Bischoff, B., Pfaender, S., Brill, F., Steinmann, E.
10.1101/2020.10.25.354571 — Posted: 2020-10-26
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
Rosenfeld, R., Noy-Porat, T., Mechaly, A., Makdasi, E., Levy, Y., Alcalay, R., Falach, R., Aftalion, M., Epstein, E., Gur, D., Chitlaru, T., Vitner, E. B., Melamed, S., Politi, B., Zauberman, A., Lazar, S., Evgy, Y., Yitzhaki, S., Shapira, S. C., Israely, T., Mazor, O.
10.1101/2020.10.26.354811 — Posted: 2020-10-26
Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain
Gan, J. L., Huang, R., Warner, G., Kelley, A., McGregor, D., Smider, V. V.
10.1101/2020.10.25.354548 — Posted: 2020-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).